Alex Mitchell, Dispatch Health
“I inherited the RNA team from the previous CFO and we’ve found them to be fantastic. They get healthcare, valuation, and they get the psychology of value just as much as the tools. They know how to get things done.”
Fairness Opinion: SPAC Target Company Valuation in Biotech
SPAC Seeks Target Company Valuation in Merger Consideration Transaction
